mannitol has been researched along with Cancer of Cervix in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arashkia, A; Azad, TM; Bolhassani, A; Modaresi, MH; Talebi, S | 1 |
| Anderson, ML; Kha, C; Ludwig, M; Mach, CM; Meaders, KM; Nguyen, D; Shumway, J; Williams-Brown, MY | 1 |
| Feldman, BH; Fraley, EE; Kjellstrand, CM | 1 |
3 other study(ies) available for mannitol and Cancer of Cervix
| Article | Year |
|---|---|
Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; Female; Gene Expression; HMGB1 Protein; Human papillomavirus 16; Humans; Immunity, Cellular; Immunity, Humoral; Immunization, Secondary; Immunoglobulin G; Interferon-gamma; Mannitol; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Oleic Acids; Papillomavirus E7 Proteins; Papillomavirus Infections; Papillomavirus Vaccines; Peptides; Recombinant Proteins; Survival Analysis; Uterine Cervical Neoplasms; Vaccination; Xenograft Model Antitumor Assays | 2017 |
A retrospective evaluation of furosemide and mannitol for prevention of cisplatin-induced nephrotoxicity.
Topics: Adult; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Diuretics; Female; Furosemide; Humans; Kidney Diseases; Mannitol; Middle Aged; Proportional Hazards Models; Renal Tubular Transport, Inborn Errors; Retrospective Studies; Risk Factors; Uterine Cervical Neoplasms | 2017 |
Mannitol intoxication.
Topics: Adult; Anuria; Female; Humans; Kidney; Mannitol; Poisoning; Postoperative Complications; Renal Dialysis; Ureteral Obstruction; Urinary Catheterization; Uterine Cervical Neoplasms | 1971 |